Polypharmacy reduction in patients treated for chronic diseases ? a patient-centered approach utilizing the interface between secondary and primary care

German Federal Ministry of Education and Research (BMBF) (Germany)0 个研究点目标入组 1,626 人开始时间: 2014年1月30日最近更新: 2017年2月20日

试验速览

暂无简介。

•Two local hospitals will recruit patients with chronic diseases and polypharmacy meeting the following inclusion criteria:
•1. Aged 60+ years
•2. Taking = 5 prescribed long-term drugs
•3. Likely to spend at least one week in the hospital

•1. Inability to take their medication by themselves
•2. Inability to give informed consent (e.g. due to dementia)
•3. Severe language difficulties
•4. Diseases that usually make poly-pharmacotherapy unavoidable (e.g. active malignoma, acquired immunodeficiencies [HIV], hemodialysis)
•5. Presumed life expectancy of less than 12 months
•Added 20/01/2017:
•6. Patients being diagnosed with any type of cancer after recruitment will be excluded from the study

发起方

German Federal Ministry of Education and Research (BMBF) (Germany)